Development of Cellular Therapeutics

Prof. Wolfgang Holter, MD
Our group focuses on the development of therapeutic strategies based on T cells modified with chimeric antigen receptors (CARs).

Clinical Cell Biology and FACS Core Unit

Assoc. Prof. René Geyeregger, PhD
With our engagement in flow cytometry and GMP-compliant work, we are a supportive interface between research and therapy.

Tumour Immunoediting

Dr. Eva Maria König, PhD
We study the role of NK cells in tumor immunoediting and aim to identify the molecular mechanisms of tumor immune evasion.